Correlation Between Unicycive Therapeutics and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Checkpoint Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Checkpoint Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Checkpoint Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Unicycive and Checkpoint is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Checkpoint Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.11 times less return on investment than Checkpoint Therapeutics. In addition to that, Unicycive Therapeutics is 1.68 times more volatile than Checkpoint Therapeutics. It trades about 0.05 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 183.00 in Checkpoint Therapeutics on September 12, 2024 and sell it today you would earn a total of 210.00 from holding Checkpoint Therapeutics or generate 114.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Checkpoint Therapeutics |
Unicycive Therapeutics and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Checkpoint Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Checkpoint Therapeutics vs. Equillium | Checkpoint Therapeutics vs. DiaMedica Therapeutics | Checkpoint Therapeutics vs. Valneva SE ADR | Checkpoint Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |